Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

153.16
+0.59000.39%
Volume:130.39K
Turnover:19.91M
Market Cap:15.62B
PE:22.45
High:154.50
Open:152.57
Low:151.80
Close:152.57
52wk High:186.12
52wk Low:122.14
Shares:102.00M
Float Shares:100.00M
Volume Ratio:0.99
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.82
EPS(LYR):4.67
ROE:22.09%
ROA:11.70%
PB:4.23
PE(LYR):32.80

Loading ...

Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 31, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2023

Major Issues Report

Form 8-K - Current report
Oct 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 05, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities